Mark Gustavson
Senior Director, Computational Pathology AstraZeneca
Seminars
Wednesday 7th October 2026
Panel Discussion: Advancing Regulatory Frameworks & Standards for Compliant Digital Pathology Co-Development
3:10 pm
Presentation Details to be Announced
Wednesday 7th October 2026
Beyond TROP2 NMR: AI & Computational Pathology for IHC-Based Diagnostics
12:50 pm
- Describing how QCS delivers human interpretable features beyond Normalized Membrane Ratio (NMR) for biomarker Dx development
- Discussing the future of computational pathology-based IHC diagnostics including the use of controls
- Examining the future of AI in the development of multimodal-based diagnostics